API - Meloxicam, Nystatin, Retinoic Acid, Omeprazole, Liothyronine Sodium, Levothyroxine Sodium (2015-02-13)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
| Lot or serial number | Companies | Brand name | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| All lots | - Recalling Firm
- Xenex Laboratories Inc
- 2402 Canoe Ave,
- Coquitlam
- V3K 6C2
- British Columbia
- CANADA
- Marketing Authorization Holder
- Not Applicable
| API - Meloxicam, Nystatin, Retinoic Acid, Omeprazole, Liothyronine Sodium, Levothyroxine Sodium | Powder | N/A | N/A |
Recalled Products
API - Meloxicam, Nystatin, Retinoic Acid, Omeprazole, Liothyronine Sodium, Levothyroxine Sodium
Lack of evidence of temperature control for cold storage
Wholesalers and compounding pharmacies